Polkinghorne KR - Search Results

1

Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, Matsushita K, Surapaneni A, Brunskill N, Chadban SJ, Chang AR, Cirillo M, Daratha KB, Gansevoort RT, Garg AX, Iacoviello L, Kayama T, Konta T, Kovesdy CP, Lash J, Lee BJ, Major RW, Metzger M, Miura K, Naimark DMJ, Nelson RG, Sawhney S, Stempniewicz N, Tang M, Townsend RR, Traynor JP, Valdivielso JM, Wetzels J, Polkinghorne KR, Heerspink HJL; Chronic Kidney Disease Prognosis Consortium. Sumida K, et al. Among authors: polkinghorne kr. Ann Intern Med. 2020 Sep 15;173(6):426-435. doi: 10.7326/M20-0529. Epub 2020 Jul 14. Ann Intern Med. 2020. PMID: 32658569 Free PMC article.

2

Native arteriovenous fistula blood flow and resistance during hemodialysis.

Polkinghorne KR, Atkins RC, Kerr PG. Polkinghorne KR, et al. Am J Kidney Dis. 2003 Jan;41(1):132-9. doi: 10.1053/ajkd.2003.50032. Am J Kidney Dis. 2003. PMID: 12500230

3

Epidemiology of vascular access in the Australian hemodialysis population.

Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Polkinghorne KR, et al. Kidney Int. 2003 Nov;64(5):1893-902. doi: 10.1046/j.1523-1755.2003.00277.x. Kidney Int. 2003. PMID: 14531825 Free article.

4

Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.

Polkinghorne KR, Zoungas S, Branley P, Villanueva E, McNeil JJ, Atkins RC, McGrath BP, Kerr PG. Polkinghorne KR, et al. Intern Med J. 2003 Nov;33(11):489-94. doi: 10.1046/j.1445-5994.2003.00420.x. Intern Med J. 2003. PMID: 14656250 Clinical Trial.

5

Time and exercise improve phosphate removal in hemodialysis patients.

Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Vaithilingam I, et al. Among authors: polkinghorne kr. Am J Kidney Dis. 2004 Jan;43(1):85-9. doi: 10.1053/j.ajkd.2003.09.016. Am J Kidney Dis. 2004. PMID: 14712431 Clinical Trial.

6

Vascular access and all-cause mortality: a propensity score analysis.

Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Polkinghorne KR, et al. J Am Soc Nephrol. 2004 Feb;15(2):477-86. doi: 10.1097/01.asn.0000109668.05157.05. J Am Soc Nephrol. 2004. PMID: 14747396

7

Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001.

Chow FY, Polkinghorne KR, Chadban SJ, Atkins RC, Kerr PG. Chow FY, et al. Among authors: polkinghorne kr. Nephrology (Carlton). 2003 Aug;8(4):177-83. doi: 10.1046/j.1440-1797.2003.00157.x. Nephrology (Carlton). 2003. PMID: 15012718

8

Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantation.

Chow FY, Polkinghorne K, Saunder A, Kerr PG, Atkins RC, Chadban SJ. Chow FY, et al. Nephrology (Carlton). 2003 Aug;8(4):212-6. doi: 10.1046/j.1440-1797.2003.00158.x. Nephrology (Carlton). 2003. PMID: 15012723 Clinical Trial.

9

Vascular access practice patterns in the New Zealand hemodialysis population.

Polkinghorne KR, McDonald SP, Marshall MR, Atkins RC, Kerr PG. Polkinghorne KR, et al. Am J Kidney Dis. 2004 Apr;43(4):696-704. doi: 10.1053/j.ajkd.2003.11.023. Am J Kidney Dis. 2004. PMID: 15042547

10

Determinants of native arteriovenous fistula blood flow.

Polkinghorne KR, Atkins RC, Kerr PG. Polkinghorne KR, et al. Nephrology (Carlton). 2004 Aug;9(4):205-11. doi: 10.1111/j.1440-1797.2004.00257.x. Nephrology (Carlton). 2004. PMID: 15363051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters